Enduring value guardian$Oscar Health(OSCR.US)Analyst rating downgrade is understandable, as subsidies may indeed be significantly reduced.
But every time an analyst downgrades, it drops again, which is really hard to take. I just said that OSCR has a good holding experience and high popularity, and non-fundamental declines are quickly corrected. It seems like this time it turned into a jinx.
My personal position is very heavy, and I'm currently considering adding a bit more.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
